HOME >> BIOLOGY >> NEWS
Finding a cure for cancer: The holy grail of science

To find a cure for cancer, the modern-day plague of our society is synonymous to finding the holy grail of science.

At a recent EuroDYNA conference in Brno, Czech Republic, scientists from around Europe came together to share their research carried out in the field of genetics and cell nucleus architecture. A greater understanding of the body's building blocks might ultimately lead to a better understanding of human disease.

Understanding DNA damage
Jiri Bartek from the Danish Cancer Society in Copenhagen in Denmark, is one step closer to understanding the route of cancer through his work on cell response to DNA damage. By using a UV laser to damage DNA strands inside tumour cells, the Copenhagen team is able to directly observe the different checkpoints in the cell.

Each time a cell divides its genetic information must be doubled in order for the genes to remain the same. A cell that is about to become tumorous can not make this genome replication and division without errors. To spot errors in the genetic material cells have evolved mechanisms to slow down or block cell division (so called cell-cycle checkpoints), promote DNA repair, or eliminate damaged, hazardous cells by engaging a cellular suicide program. How cells make the choice between life and death in response to DNA damage is critical not only for the fate of each cell, but also for avoiding life-threatening diseases such as cancer.

In cells with an early pre-tumorous change, the entire checkpoint network is activated. The system puts an end to such cells or blocks their division by a process of cellular senescence. On the other hand, defects in the DNA damage response machinery, or a phenomenon of checkpoint adaptation (when the cell arrest is long-term and not irreversible) may allow the cell to escape from the DNA damage-imposed blockade and despite its damaged DNA, it may multiply. This can give birth to a tumour.

Bartek and his team
'"/>

Contact: Sofia Valleley
svalleley@esf.org
33-388-762-149
European Science Foundation
21-Nov-2006


Page: 1 2 3 4

Related biology news :

1. Finding protection from tumor growth in unexpected places
2. Finding the white wine difference
3. Finding an answer to Darwins Dilemma
4. Finding the right mix: A biomaterial blend library
5. Finding paves way for better treatment of autoimmune disease
6. Finding about cellular microtubule rigidity could lead to development of new nano-materials
7. Findings by Einstein scientists reveal possible strategy against obesity, diabetes and infertility
8. Finding of a new molecular marker of resistance to chemotherapy in breast cancer
9. Finding a cellular Neverland: How stem cells stay childlike
10. Finding a virus is not all bad news
11. Finding life on Mars and outer space begins by examining Earths inner space

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: